# The ABSORB BTK (Below The Knee) Clinical Investigation

> **NCT01341340** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 2 (actual)

## Conditions studied

- Atherosclerosis
- Peripheral Artery Disease
- Peripheral Vascular Disease
- PAD
- Claudication
- Critical Limb Ischemia
- Lower Limb Disease
- Peripheral Arterial Occlusive Disease
- PAOD
- PVD

## Interventions

- **DEVICE:** Everolimus Eluting BVS

## Key facts

- **NCT ID:** NCT01341340
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Discontinued due to poor enrollment. Insufficient number of patients enrolled to permit a statistically rigorous assessment of safety and efficacy.
- **Last updated:** 2019-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341340, "The ABSORB BTK (Below The Knee) Clinical Investigation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01341340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*